Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 29 (RPL31P29)

Target: RPL31P29
Molecular classification: Other (specifically, it is a pseudogene; not a receptor, enzyme, ion channel, transporter, Transcription factor, or histone modifier)

Overview

Ribosomal protein L31 pseudogene 29 (RPL31P29) is a processed, non-coding pseudogene in the human genome, found in the gene database under identifiers including HGNC: 36647 and NCBI Gene: 100270990. It shares sequence homology with the functional ribosomal protein L31 gene, but does not encode a functional ribosomal protein and is not known to produce a stable transcript or protein product in humans. Pseudogenes like RPL31P29 may exist due to gene duplication or retrotransposition events, but are generally regarded as non-functional genetic elements. The protein-coding parent gene, ribosomal protein L31 (RPL31), is a component of the 60S ribosomal subunit and involved in protein synthesis, but RPL31P29 does not contribute to these functions. This entry is not a therapeutically relevant molecular target. If you require structured data for canonical therapeutic targets, the entry should be marked as incorrect or excluded.

Other names: RPL31_9_773RPL31P29Human RPL31P29 (100270990)Ribosomal protein L31 pseudogene 29

Mechanism of action

None (no drugs target this pseudogene)

Biological functions

None (as a pseudogene, it does not have a proven biological function; canonical RPL31 is a ribosomal protein involved in translation, but pseudogenes generally do not encode functional proteins)

Disease associations

None (no proven disease association for the pseudogene; no evidence it acts as a risk factor, biomarker, or participant in human disease. Diseases listed for the functional RPL31 gene do not apply to the pseudogene)

Safety considerations

None (not targeted therapeutically; no safety data relevant)

Interacting drugs

None (no known drugs interact with this pseudogene, as it does not produce a functional protein)

Biomarkers

None (not used for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 29 (RPL31P29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 29 (RPL31P29).

Explore the full profile